Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.36 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.36 |
| ▸ | CACNB2 | Q08289 | 1/20 | 0.36 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7738560 | 1.00 | TSHR (0.56) | TSHRALDH1A1ABCG2CACNA2D1CACNB2 | |
| SCHEMBL1888612 | 0.98 | TSHR (0.52) | TSHRALDH1A1ABCG2CACNA2D1CACNB2 | |
| SCHEMBL3341875 | 0.91 | — | — | |
| SCHEMBL6336602 | 0.83 | TRPV1 (0.47) | ALDH1A1FAAHTRPV1PTGS1PPARG | |
| SCHEMBL10880422 | 0.81 | — | — | |
| SCHEMBL9142379 | 0.79 | TSHR (0.64) | TSHRALDH1A1ABCG2FAAHTRPV1 | |
| SCHEMBL3499793 | 0.79 | TSHR (0.64) | TSHRALDH1A1ABCG2FAAHTRPV1 | |
| SCHEMBL4354065 | 0.79 | TSHR (0.64) | TSHRALDH1A1ABCG2FAAHTRPV1 | |
| SCHEMBL9140978 | 0.79 | TSHR (0.64) | TSHRALDH1A1ABCG2FAAHTRPV1 | |
| SCHEMBL9141366 | 0.79 | TSHR (0.64) | TSHRALDH1A1ABCG2FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4906559-A | Light-sensitive silver halide photographic material | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1990-03-06 | — | — | US | claimed |
| US-6911553-B1 | Osteoblast-specific mitogens and drugs containing such compounds | ROCHE DIAGNOSTICS GMBH (DE) | 2005-06-28 | — | — | US | disclosed |
| US-20050014723-A1 | Osteoblast-specific mitogens and drugs containing such compounds | ESSWEIN ANGELIKA (DE) | 2005-01-20 | — | — | US | disclosed |
| EP-1019062-B1 | OSTEOBLAST-SPECIFIC MITOGENS AND DRUGS CONTAINING SUCH COMPOUNDS | ROCHE DIAGNOSTICS GMBH (DE) | 2003-02-05 | — | — | EP | disclosed |
| US-6444832-B1 | OSTEOPOROSIS | ESSWEIN ANGELIKA (DE) | 2002-09-03 | — | — | US | disclosed |
| US-6337170-B1 | DYE CONCENTRATION, IMAGE FASTNESS | FUJI PHOTO FILM CO., LTD. (JP) | 2002-01-08 | — | — | US | disclosed |
| EP-0865422-B1 | USE OF AMINOALCOHOLDERIVATIVES AS DRUGS, DERIVATIVES AND PROCESS FOR THEIR PREPARATION | ROCHE DIAGNOSTICS GMBH (DE) | 2001-07-11 | — | — | EP | disclosed |
| US-6197759-B1 | ADMINISTERING LYSOPHOSPHATIDYLIC ACID DERIVATIVE | ROCHE DIAGNOSTICS GMBH (DE) | 2001-03-06 | — | — | US | disclosed |
| EP-0906759-A1 | Novel osteoblastic specific mitogenes: process for their preparation and drugs containing these compounds | Roche Diagnostics GmbH (DE) | 1999-04-07 | — | — | EP | disclosed |
| US-4906559-A | Light-sensitive silver halide photographic material | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1990-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014723-A1 | Osteoblast-specific mitogens and drugs containing such compounds | LPAR1, LPAR2, LPAR4 | TSHR 2249/4885ALDH1A1 1997/4885ABCG2 2239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.